The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

Frequent donors were more likely to have different genetic changes in their blood stem cells, scientists found.

A new artificial intelligence (AI) tool can simultaneously assess blood samples for ... genes encoding immune cell receptors to identify patients with COVID-19, HIV, type 1 diabetes, lupus ...

Pamela Bjorkman of the California Institute of Technology won the prize for ‘offering new hope in the fight against ...

When people donate blood, stem cells in the bone marrow make new blood ... an organ transplant or tested positive for Human Immunodeficiency Virus (HIV), among other reasons.

An international group of researchers has identified an important mechanism that enables stem cells to evade immune rejection ...

Men who had given blood more than 100 times in their life were more likely to have blood cells carrying certain beneficial ...